Cancer Vaccines: “Transforming Vaccine Delivery Through Innovation”
Session Title:
Cancer Vaccines: “Transforming Vaccine Delivery Through Innovation”
When: 12th October 2026. From 1-2pm
Online event
Session Outline:
This presentation explores the role of cancer vaccines in transforming cancer treatment and prevention by leveraging the immune system, highlighting key innovations such as personalised and mRNA-based vaccines alongside their manufacturing, storage, and governance challenges. It also emphasises the critical role of pharmacy in ensuring clinical safety, regulatory compliance, and operational delivery, enabling the successful implementation of advanced vaccine therapies within healthcare systems.
Biography:
Ilves Sanna is Head of Pharmacy Clinical Trials and Aseptic Services at The Royal Marsden NHS Foundation Trust, where I lead the delivery of complex clinical trials and aseptic services supporting oncology research and advanced therapies.
I have played a key role in developing and implementing pharmacy-led models for the delivery of innovative therapies, including personalised cancer vaccines, ensuring compliance with regulatory standards and supporting national and multi-centre research initiatives. My professional interests focus on advancing clinical trial infrastructure, enabling safe and efficient delivery of novel therapies, and strengthening the role of pharmacy in innovation, precision medicine, and cancer vaccine development.
Click HERE to register for the online event.
